Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
PCB Bancorp
PCB
$401M
| $1.41M | ﹤0.01% |
+85,670
| New | +$1.42M |
|
|
CTRA
2452
DELISTED
Coterra Energy
CTRA
| $1.41M | ﹤0.01% |
80,100
-1,293,700
| -94% | -$24.8M |
|
|
EMMS
2453
DELISTED
Emmis Communications Corp
EMMS
| $1.41M | ﹤0.01% |
298,685
+56,326
| +23% | +$275K |
|
2454
Amdocs
DOX
$6.2B
| $1.4M | ﹤0.01% |
21,200
-344,600
| -94% | -$22.1M |
|
2455
Radcom
RDCM
$172M
| $1.4M | ﹤0.01% |
152,733
-300
| -0.2% | -$2.56K |
|
2456
HUB Group
HUBG
$2.47B
| $1.4M | ﹤0.01% |
60,072
+19,200
| +47% | +$407K |
|
2457
Genasys
GNSS
$78.8M
| $1.39M | ﹤0.01% |
416,161
-5,399
| -1% | -$19.7K |
|
|
NE
2458
DELISTED
Noble Corporation
NE
| $1.39M | ﹤0.01% |
+1,097,637
| New | +$1.88M |
|
2459
Coffee Holding Co
JVA
$20M
| $1.39M | ﹤0.01% |
356,222
-29,537
| -8% | -$119K |
|
2460
E.W. Scripps
SSP
$322M
| $1.39M | ﹤0.01% |
104,600
-447,300
| -81% | -$6.16M |
|
2461
Amerant Bancorp
AMTB
$1.14B
| $1.39M | ﹤0.01% |
66,100
+42,900
| +185% | +$786K |
|
|
BREW
2462
DELISTED
Craft Brew Alliance, Inc.
BREW
| $1.38M | ﹤0.01% |
168,048
-72,800
| -30% | -$911K |
|
|
FSB
2463
DELISTED
Franklin Financial Network, Inc.
FSB
| $1.37M | ﹤0.01% |
45,300
+23,000
| +103% | +$666K |
|
2464
Rimini Street
RMNI
$471M
| $1.37M | ﹤0.01% |
312,349
+154,300
| +98% | +$751K |
|
|
STRS
2465
DELISTED
STRATUS PPTYS INC
STRS
| $1.37M | ﹤0.01% |
46,500
+1,300
| +3% | +$35.5K |
|
|
UBP
2466
DELISTED
Urstadt Biddle Properties Inc.
UBP
| $1.36M | ﹤0.01% |
72,200
+12,300
| +21% | +$212K |
|
2467
Invesco Financial Preferred ETF
PGF
$667M
| $1.36M | ﹤0.01% |
+72,400
| New | +$1.35M |
|
|
CDTX
2468
DELISTED
Cidara Therapeutics
CDTX
| $1.35M | ﹤0.01% |
33,784
+3,247
| +11% | +$109K |
|
|
STEL
2469
DELISTED
Stellar Bancorp
STEL
| $1.35M | ﹤0.01% |
48,300
+35,400
| +274% | +$1.01M |
|
2470
Coca-Cola Consolidated
COKE
$12.4B
| $1.35M | ﹤0.01% |
44,290
-114,220
| -72% | -$3.57M |
|
2471
CryoPort
CYRX
$763M
| $1.35M | ﹤0.01% |
+82,300
| New | +$1.65M |
|
2472
Matthews International
MATW
$725M
| $1.34M | ﹤0.01% |
37,953
+13,786
| +57% | +$453K |
|
|
ISEE
2473
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.34M | ﹤0.01% |
1,198,255
-35,246
| -3% | -$41K |
|
|
ATHX
2474
DELISTED
Athersys, Inc. Common Stock
ATHX
| $1.34M | ﹤0.01% |
40,277
-816
| -2% | -$28.9K |
|
2475
Axcelis
ACLS
$4.29B
| $1.33M | ﹤0.01% |
78,099
-41,500
| -35% | -$663K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.